Neglected Disease Research and Development: How Much Are We Really Spending?

Abstract

he need for new pharmaceutical tools to prevent and treat neglected diseases is widely accepted The creation of a vaccine for HIV/AIDS, more effective diagnostics for tuberculosis (TB), and better treatments for leishmaniasis and sleeping sickness would greatly improve health in the developing world in line with the United Nations Millennium Development Goals. However, funders wishing to invest in this vitally important area currently face an information gap.